Juan Carlos Ruiz Ruiz-rekin lankidetzan egindako argitalpenak (16)

2016

  1. Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria

    Journal of Hepatology, Vol. 65, Núm. 4, pp. 776-783

2010

  1. A phase i clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma

    Cancer Gene Therapy, Vol. 17, Núm. 12, pp. 837-843

2005

  1. Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8

    International Journal of Cancer, Vol. 116, Núm. 2, pp. 275-281

  2. Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas

    Journal of Clinical Oncology, Vol. 23, Núm. 5, pp. 999-1010

  3. Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients

    Gastroenterology, Vol. 128, Núm. 7, pp. 1787-1795

2004

  1. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors

    Journal of Clinical Oncology, Vol. 22, Núm. 8, pp. 1389-1397

2002

  1. Gene therapy for liver diseases: Recent strategies for treatment of viral hepatitis and liver malignancies

    Gut, Vol. 50, Núm. 1, pp. 130-135

  2. Tracing transgene expression in cancer gene therapy: A requirement for rational progress in the field

    Molecular Imaging and Biology, Vol. 4, Núm. 1, pp. 27-33

2001

  1. Gene therapy of hepatocellular carcinoma

    Digestive Diseases, Vol. 19, Núm. 4, pp. 324-332

  2. Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12

    Gene Therapy, Vol. 8, Núm. 4, pp. 259-267

2000

  1. Liver damage using suicide genes: A model for oval cell activation

    American Journal of Pathology, Vol. 157, Núm. 2, pp. 549-559

  2. Terapia génica de las enfermedades hepáticas

    Gastroenterologia y Hepatologia, Vol. 23, Núm. 8, pp. 394-402

1999

  1. Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas

    Gene Therapy, Vol. 6, Núm. 10, pp. 1779-1784

1994

  1. Partial splenic embolization for the treatment of hypersplenism in cirrhosis

    Revue Francaise de Gastro-Enterologie

1993

  1. Partial splenic embolization for the treatment of hypersplenism in cirrhosis

    Hepatology, Vol. 18, Núm. 2, pp. 309-314

1992

  1. Hepatitis B and C viral infections in patients with hepatocellular carcinoma

    Hepatology, Vol. 16, Núm. 3, pp. 637-641